Bactiquant A/S (9JX) Stock Price & News

All values in DKK	Sep. 2025	Des. 2025	Mrt. 2026	Jun. 2026
Revenue	2,10 m	2,10 m	2,66 m	2,66 m
Cost of goods sold	2,76 m	2,76 m	2,34 m	2,34 m
Cost of revenue	2,76 m	2,76 m	2,34 m	2,34 m
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	1,98 m	1,98 m	2,16 m	2,16 m
Operating expense	2,40 m	2,40 m	2,54 m	2,54 m
Total operating expenses	5,17 m	5,17 m	4,88 m	4,88 m
Operating income	-3,07 m	-3,07 m	-2,22 m	-2,22 m
Other non operating income	-	-	-	-
EBT including unusual items	-3,45 m	-3,45 m	-2,39 m	-2,39 m
EBT excluding unusual items	-3,45 m	-3,45 m	-2,39 m	-2,39 m
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	-	-	-	-
Net income	-3,45 m	-3,45 m	-2,39 m	-2,39 m
Net profit margin	-163,85%	-163,85%	-89,71%	-89,71%
Earnings per share	-	-	-	-
Interest and investment income	27,48 k	27,48 k	53,33 k	53,33 k
Interest expense	-407,50 k	-407,50 k	-227,22 k	-227,22 k
Net interest expenses	-380,02 k	-380,02 k	-173,89 k	-173,89 k
Depreciation and amortization charges	407,77 k	407,77 k	382,11 k	382,11 k
EBITDA	-2,85 m	-2,94 m	-1,83 m	-1,83 m
Gain or loss from assets sale	-	-	-	-

Ask anything